CIPLA vs RELIANCE
Head-to-head DCF comparison · Cipla Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
CIPLA
Cipla Limited
Pharma
₹1,377
Near Fair ValueRELIANCE
Reliance Industries
Oil & Gas
₹1,269
Near Fair Value| Metric | CIPLA | RELIANCE |
|---|---|---|
| Verdict | Near Fair Value | Near Fair Value |
| YieldIQ Score | 45/100 | 67/100 |
| Fair Value | ₹1,218 | ₹1,507 |
| Current Price | ₹1,377 | ₹1,269 |
| Discount to FV | -11.5% | +18.7% |
| Moat | Narrow | Moderate |
| Piotroski F-Score | 5/9 | 4/9 |
| ROE | 11.3% | 8.9% |
| Debt / Equity | 0.02 | 0.37 |
| EV / EBITDA | 18.3× | 9.8× |
| Market Cap | ₹1.11 Lakh Cr | ₹17.18 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.